source
- BeOne invests $300 million in New Jersey plant, adding small-molecule capacity and 120 jobsBeOne Medicines announced a $300 million investment to expand its manufacturing campus in Hopewell, New Jersey. The expansion will include a three‑story, 145,000‑square‑foot building for small‑mol…
- Biogen looks to Apellis acquisition to boost lagging Leqembi salesBiogen CEO Chris Viehbacher said the company's Alzheimer's drug Leqembi has underperformed since its 2023 launch. The drug, co-developed with Eisai, has struggled to meet sales expectations, promp…